CPAP Device In-lab Assessment NZ

NCT02948010 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2017-06-27

No results posted yet for this study

Summary

The purpose of this trial is to assess device performance against participants in an overnight study to ensure the product meets user and clinical requirements

Conditions

Interventions

DEVICE

Auto CPAP + comfort feature A

Auto CPAP + comfort feature A using Fisher \& Paykel Healthcare CPAP Device

DEVICE

Auto CPAP with comfort feature B

Auto CPAP with comfort feature B using Fisher \& Paykel Healthcare CPAP Device

DEVICE

Auto CPAP with no comfort feature

Auto CPAP with no comfort feature using Fisher \& Paykel Healthcare CPAP Device

DEVICE

Auto CPAP with comfort feature A+B

Auto CPAP with comfort feature A+B using Fisher \& Paykel Healthcare CPAP Device

DEVICE

CPAP with comfort feature A

CPAP with comfort feature A using Fisher \& Paykel Healthcare CPAP Device

DEVICE

CPAP with comfort feature B

CPAP with comfort feature B using Fisher \& Paykel Healthcare CPAP Device

DEVICE

CPAP with no comfort feature

CPAP with no comfort feature using Fisher \& Paykel Healthcare CPAP Device

DEVICE

CPAP with comfort feature A + B

CPAP with comfort feature A + B using Fisher \& Paykel Healthcare CPAP Device

DEVICE

CPAP at Sub therapeutic level

CPAP at Sub therapeutic level using Fisher \& Paykel Healthcare CPAP Device

Sponsors & Collaborators

  • Fisher and Paykel Healthcare

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • New Zealand

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02948010 on ClinicalTrials.gov